Novartis' manufacturing hub in Stein, Switzerland (Novartis)

Swiss CD­MO Celonic finds a home at No­var­tis' Stein hub, plans to add 250 new jobs cen­tered on next-gen drugs

The out­sourc­ing mar­ket for cell and gene ther­a­pies has stayed red-hot in re­cent months as some of the biggest CD­MOs — and even ma­jor drug­mak­ers — are div­ing in. Now, a Swiss CD­MO wants a big­ger piece of the ac­tion, and it’s look­ing to set up shop in No­var­tis’ fledg­ling life sci­ences hub in Stein.

Celonic plans to build a 91,500-square-foot man­u­fac­tur­ing cen­ter fo­cused on cell and gene ther­a­pies, next-gen vac­cines and oth­er “in­no­v­a­tive” drugs as part of a two-part ex­pan­sion at No­var­tis’ Rhine Val­ley hub, the CD­MO said last week.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.